Latest filing published 23 Jun 2020 for Compass Therapeutics, Inc., €286k.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Philip Ferneau: trading record in brief
This profile gathers the share dealings of Philip Ferneau in Compass Therapeutics, Inc. We count 2 filings, every one of them for a trade on 19 June 2020.
Every open-market trade on record is a purchase: 2 purchases worth €1.4M, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
On 23 June 2020 came the latest disclosure, an open-market purchase for €286k in Compass Therapeutics, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Philip Ferneau
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 64,066 shares@ US$5.00Common StockSEC:0001213900-20-015637:0Canonical exit: 17 Sept 2020 (T+90)
- 250,000 shares@ US$5.00Common StockSEC:0001213900-20-015637:1Canonical exit: 17 Sept 2020 (T+90)
2 of 2 declarations